STANDARD BIOTOOLS INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$24M
Gross Profit
$11M
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) |
|---|---|
| Revenue | $24M |
| COGS | $12M |
| Gross Profit | $11M |
| R&D | $8M |
| SG&A | $25M |
| D&A | $1M |
| Other OpEx | $0 |
| Operating Income | $0 |
| Interest Exp. | $0 |
| Other Non-Op | $0 |
| Pretax Income | $0 |
| Tax | $0 |
| Net Income | $0 |
QuarterCharts · SEC EDGAR data · LAB · Comparing FY2025 (Q4) vs FY2024 (Q4)